{
    "2018-04-09": [
        [
            {
                "time": "2018-04-10",
                "original_text": "医疗器材迎政策利好，龙头企业受益",
                "features": {
                    "keywords": [
                        "医疗器材",
                        "政策利好",
                        "龙头企业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-15",
                "original_text": "[增持评级]医药生物行业周报：仿制药进口替代、集中度提升趋势进一步明确",
                "features": {
                    "keywords": [
                        "医药生物",
                        "仿制药",
                        "进口替代",
                        "集中度提升"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "五大基金经理研判2018年医药投资",
                "features": {
                    "keywords": [
                        "基金经理",
                        "医药投资",
                        "研判"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "政策促仿制药进口替代加速 五股或闻风而动",
                "features": {
                    "keywords": [
                        "政策",
                        "仿制药",
                        "进口替代",
                        "加速",
                        "个股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-18",
                "original_text": "[推荐评级]医药生物行业周报：中美贸易摩擦加剧 继续加仓医药",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中美贸易摩擦",
                        "加仓医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "一季度混基中邮人品爆发业绩绝尘 北信瑞丰等惨垫底",
                "features": {
                    "keywords": [
                        "一季度",
                        "混基",
                        "中邮人品",
                        "北信瑞丰"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-17",
                "original_text": "政策促仿制药进口替代加速 机构看好8只龙头股",
                "features": {
                    "keywords": [
                        "政策",
                        "仿制药",
                        "进口替代",
                        "加速",
                        "龙头股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}